Search

Your search keyword '"Korva M"' showing total 135 results

Search Constraints

Start Over You searched for: Author "Korva M" Remove constraint Author: "Korva M"
135 results on '"Korva M"'

Search Results

Catalog

Books, media, physical & digital resources

3. COVID-19 disease: monitoring of antibodies against SARS-CoV-2 virus in serum of a vitamin D sufficient male.

9. Distinct haplotype structure at the innate immune receptor Toll-like receptor 2 (TLR2) across bank vole populations and lineages in Europe

11. Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who European region, June 2013

12. Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia.

13. First multicentre evaluation of serological and molecular diagnostic assays for Crimean-Congo hemorrhagic fever

15. Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome.

16. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

17. Comparative specificity and sensitivity of ns1-based serological assays for the detection of flavivirus immune response

18. Public health and clinical response to an mpox outbreak in Slovenia: case study, 2022-2023.

19. Metagenomic Sequencing for Diagnosing Listeria-Induced Rhombencephalitis in Patient and Contaminated Cheese Samples: A Case Report.

20. Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity.

21. MetaAll: integrative bioinformatics workflow for analysing clinical metagenomic data.

22. Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins.

23. Serological response after COVID-19 infection compared to vaccination against COVID-19 in children with autoimmune rheumatic diseases.

24. Influenza A, Influenza B, human respiratory syncytial virus and SARSCoV-2 molecular diagnostics and epidemiology in the post COVID-19 era.

25. Elevated levels of serum muscle enzymes in the initial phase of tick-borne encephalitis.

26. Efficient SARS-CoV-2 variant detection and monitoring with Spike Screen next-generation sequencing.

27. Sequencing analysis of SARS-CoV-2 cases in Slovenian long-term care facilities to support outbreak control.

28. Enrichment of SARS-CoV-2 sequence from nasopharyngeal swabs whilst identifying the nasal microbiome.

29. Herpesviridae and Atypical Bacteria Co-Detections in Lower Respiratory Tract Samples of SARS-CoV-2-Positive Patients Admitted to an Intensive Care Unit.

30. Review of virological methods for laboratory diagnosis and characterization of monkeypox virus (MPXV): lessons learned from the 2022 Mpox outbreak.

31. Comparing COVID-19 severity in patients hospitalized for community-associated Delta, BA.1 and BA.4/5 variant infection.

32. Hantavirus Pulmonary Syndrome Caused by Puumala Orthohantavirus-A Case Report and Literature Review.

33. Evidence of tick-borne encephalitis virus neutralizing antibodies in Serbian individuals exposed to tick bites.

34. External quality assessment of orthohantavirus and lymphocytic choriomeningitis virus molecular detection and serology in Europe, 2021.

35. Molecular epidemiology of the 2022 monkeypox virus outbreak in Slovenia.

36. Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood.

37. Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination.

38. Dendritic cell activation and cytokine response in vaccine breakthrough TBE patients after in vitro stimulation with TBEV.

39. Intrahost Monkeypox Virus Genome Variation in Patient with Early Infection, Finland, 2022.

40. Comparison of laboratory and immune characteristics of the initial and second phase of tick-borne encephalitis.

41. In human astrocytes neurotropic flaviviruses increase autophagy, yet their replication is autophagy-independent.

42. Milder outcomes of SARS-CoV-2 genetically confirmed reinfections compared to primary infections with the delta variant: A retrospective case-control study.

43. Vector-Borne Tularemia: A Re-Emerging Cause of Cervical Lymphadenopathy.

44. Evaluation of Two Broadly Used Commercial Methods for Detection of Respiratory Viruses with a Recently Added New Target for Detection of SARS-CoV-2.

45. Complete Genome Sequencing of Tick-Borne Encephalitis Virus Directly from Clinical Samples: Comparison of Shotgun Metagenomic and Targeted Amplicon-Based Sequencing.

46. Comparative Evaluation of Six SARS-CoV-2 Real-Time RT-PCR Diagnostic Approaches Shows Substantial Genomic Variant-Dependent Intra- and Inter-Test Variability, Poor Interchangeability of Cycle Threshold and Complementary Turn-Around Times.

47. Unique Clinical, Immune, and Genetic Signature in Patients with Borrelial Meningoradiculoneuritis 1 .

48. Exposure to dust, endotoxins and microbes in Finnish vegetable greenhouses.

49. Clinical and Laboratory Characteristics and Outcome of Illness Caused by Tick-Borne Encephalitis Virus without Central Nervous System Involvement.

50. Transmission of SARS-CoV-2 from Human to Domestic Ferret.